FDA.reportPublic FDA data

10 ML rituximab-arrx 10 MG/ML Injection

RxCUI
2472327
RxNorm name
10 ML rituximab-arrx 10 MG/ML Injection
Display name
10 ML rituximab-arrx 10 MG/ML Injection
Full name
10 ML rituximab-arrx 10 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761140Riabnirituximab-arrx351(k) BiosimilarRx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
da1c4de7-0e5b-4f72-97ec-7a8d368f085friTUXimab-arrx 100 MG in 10 ML Injection [PSN] · 10 ML rituximab-arrx 10 MG/ML Injection [SCD] · rituximab-arrx 100 MG per 10 ML Injection [SY]39These highlights do not include all the information needed to use RIABNI safely and effectively. See full prescribing information for RIABNI. RIABNI ® (rituximab-arrx) injection, for intravenous use Initial U.S. Approval: 2020 RIABNI (rituximab-arrx) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences between the20250912